Cardiol Therapeutics (CRDL) Intangibles (2020 - 2024)

Cardiol Therapeutics has reported Intangibles for 5 years, with the latest figure at $549219.5 in Q4 2024.

• For the quarter ending Q4 2024, Intangibles rose 255.45% year-over-year to $549219.5; the trailing twelve-month figure through Dec 2024 stood at $549219.5 (up 255.45% YoY), and the FY2024 full-year result was $549219.5, up 255.45% from the prior year.
• Intangibles for Q4 2024 stood at $549219.5, up from $122931.0 in the prior quarter.
• The five-year high for Intangibles was $549219.5 in Q4 2024, with the low at -$307800.1 in Q4 2021.
• Historically, Intangibles has averaged $177135.3 across 5 years, with a median of $202448.2 in 2023.
• The largest YoY upside for Intangibles was 255.45% in 2024 against a maximum downside of 34.62% in 2024.
• Cardiol Therapeutics' Intangibles stood at -$232830.2 in 2020, then tumbled by 32.2% to -$307800.1 in 2021, then jumped by 170.56% to $217181.5 in 2022, then fell by 28.85% to $154515.4 in 2023, then soared by 255.45% to $549219.5 in 2024.
• The last three Intangibles figures came in at $549219.5 (Q4 2024), $122931.0 (Q2 2024), and $140442.7 (Q1 2024), per Business Quant data.